Neurovascular Devices Market 2030: How North America Dominates the Landscape

The global neurovascular devices market was valued at USD 3.19 billion in 2024 and is expected to experience a steady growth rate, with a compound annual growth rate (CAGR) of 6.01% projected from 2025 to 2030. This growth is being driven by several key factors, including the rising prevalence of neurovascular disorders, ongoing advancements in medical technology, and an increasing shift toward minimally invasive procedures. As the incidence of conditions such as stroke, cerebral aneurysms, and arteriovenous malformations (AVM) continues to rise, there is a growing demand for effective and innovative treatment options to address these complex health issues.

Neurovascular devices, which fall under the umbrella of interventional neurology, play a crucial role in diagnosing and treating disorders of the central nervous system (CNS) and brain blood vessels. These devices are primarily used in procedures that involve the brain's vasculature, such as endovascular, catheter-based treatments. Key techniques in interventional neurology include angiography and fluoroscopy, which allow for real-time imaging during procedures. One of the most widely used techniques in this field is catheter-based angiography. This method, one of the oldest in-vivo imaging techniques for brain blood vessels, is essential in diagnosing a wide range of neurological diseases, including cerebral aneurysms, arteriovenous malformations (AVM), intracranial stenosis, arteriovenous fistula, and vasculitis. Through the use of these devices and imaging techniques, healthcare providers can accurately identify and treat various neurovascular conditions, improving patient outcomes and driving the demand for these technologies.

Gather more insights about the market drivers, restrains and growth of the Neurovascular Devices Market

Regional Insights

North America Neurovascular Devices Market
The North American neurovascular devices market is poised to lead in 2024, commanding a share of 27.62%. This dominance is attributed to the presence of major manufacturers like Penumbra, Inc., Stryker Corporation, Johnson & Johnson, and Merit Medical Systems, Inc. operating in the region. In February 2023, Phenox Inc. announced that the FDA had cleared their pRESET Thrombectomy Device for treating acute ischemic stroke. This product, which has been available in Europe for over ten years, has now gained approval for use in the U.S. The market is also being fueled by a growing prevalence of neurological disorders and an increasing demand for minimally invasive surgical procedures, contributing to the expansion of the neurovascular devices market in North America.

U.S.
The U.S. neurovascular devices market is witnessing rapid growth, primarily driven by the rising incidence of cerebrovascular diseases, including strokes, aneurysms, and arteriovenous malformations. Contributing factors include an aging population and the increasing prevalence of lifestyle-related conditions like hypertension and diabetes, which are fueling the demand for neurovascular interventions. Advances in technology, particularly the development of minimally invasive devices such as flow diverters, stent retrievers, and embolic coils, are improving patient outcomes and further supporting market expansion. Additionally, the U.S. Food and Drug Administration (FDA) plays a crucial role in accelerating innovation through the fast-tracking of breakthrough devices. Collaborations between medical device companies and healthcare providers to develop novel solutions are also fostering significant growth in the sector.

Canada
Canada's neurovascular devices market held a substantial share in 2024, supported by the country’s healthcare coverage and mandatory insurance, which facilitate the adoption of advanced medical technologies. The industrialization of regions like Quebec and Ontario is expected to further boost market growth due to the entry of new market players. Additionally, growing awareness and the support of organizations such as the Canadian Neurological Sciences Federation and the Canadian Neurovascular Health Society, which focus on neurovascular research, are likely to foster continued growth in the Canadian market.

Europe Neurovascular Devices Market Trends

The European neurovascular devices market is also experiencing robust growth, largely driven by the increasing geriatric population and the rapid advancements in reconstructive surgery technologies. These innovations are expected to propel further market expansion. The growing adoption of advanced neurovascular devices and a rise in the number of cranio-maxillofacial (CMF) surgeries are also key factors expected to contribute to the market's growth. Among the major markets in Europe, the UK and Germany are the leaders. However, the market’s growth in some developing European countries is hindered by a lack of supportive reimbursement policies.

United Kingdom (UK

The neurovascular devices market in the UK is poised for significant growth, driven by increased awareness surrounding the treatment of acute ischemic stroke and the presence of several leading market players. According to NHS England, over 100,000 people experience a stroke annually, and there are 1.3 million stroke survivors in the UK. In addition, a January 2023 study revealed the UK government's commitment to implementing a Major Conditions Strategy, which includes addressing stroke and other cardiovascular diseases as leading causes of illness and death in the country.

Germany
Germany's neurovascular devices market is also experiencing significant growth, primarily due to the rising incidence of acute ischemic strokes, which have led to an increase in mechanical thrombectomy procedures. The high adoption of technologically advanced neurovascular products is further driving market growth in the country. For instance, a study published in the NCBI journal revealed that approximately 2 million adults in Germany suffer from unruptured intracranial aneurysms. Moreover, a population-based study conducted in two German cities, published by S. Karger AG in January 2023, found the incidence of Traumatic Brain Injury (TBI) to be 13 and 17 cases per 100,000 population.

Asia Pacific Neurovascular Devices Market Trends

The Asia Pacific region is witnessing rapid growth in the neurovascular devices market, driven by a high prevalence of neurological disorders, significant improvements in medical infrastructure, and the availability of novel products. The large patient population suffering from conditions such as brain aneurysms and strokes, along with the growing need for advanced and cost-effective healthcare solutions, presents considerable growth opportunities in this region.

China
The neurovascular devices market in China is expanding at a lucrative rate, fueled by the presence of several local and key global players and the rising incidence of stroke cases. A study published in JAMA Network Open in March 2023 revealed that the overall incidence of stroke in China was 500 per 100,000 person-years for individuals older than 40 years. This growing stroke incidence is expected to significantly drive the market's growth in China in the coming years.

Latin America Neurovascular Devices Market Trends

The neurovascular devices market in Latin America is experiencing notable growth, largely due to increased government investment in healthcare and the growing demand for advanced medical technologies. Countries like Brazil and Mexico, which have the largest economies in the region, have allocated substantial resources to healthcare, making high-cost neurovascular devices more accessible to public hospitals. This trend is expected to continue driving the market's growth.

Middle East and Africa Neurovascular Devices Market Trends

The neurovascular devices market in the Middle East and Africa (MEA) is witnessing growth, largely driven by the rising incidence of neurovascular diseases such as strokes, aneurysms, and other cerebrovascular conditions. This increase is attributable to the growing prevalence of risk factors such as hypertension, diabetes, obesity, and sedentary lifestyles, which are major contributors to neurovascular diseases.

Saudi Arabia

The neurovascular devices market in Saudi Arabia is growing due to the rising prevalence of neurovascular conditions, which is driving the demand for advanced diagnostic and treatment devices. The aging population in Saudi Arabia is contributing to a higher risk of cerebrovascular issues, including strokes. The ongoing healthcare modernization efforts under the Saudi Vision 2030 initiative are further fueling market growth, as the government continues to invest in advanced medical technologies and healthcare infrastructure.

Browse through Grand View Research's Category Medical Devices Industry Research Reports.

• The global electrophysiology devices market size was estimated at USD 12.9 billion in 2024 and is projected to grow at a CAGR of 15.1% from 2025 to 2030. 
• The global preclinical CRO market size was valued at USD 5.72 billion in 2023 and is anticipated to grow at a CAGR of 8.7% from 2024 to 2030.

Key Neurovascular Devices Company Insights

Key market players are focusing on the launch of innovative types of medical devices, growth strategies, and technological advancements. For instance, in April 2024, MicroVention, Inc., a Terumo Corporation wholly owned subsidiary, announced the completion of its first enrollment in STRAIT, a multi-center, prospective observational EU study to evaluate the performance and safety of the BOBBY balloon guide catheter for endovascular treatment of acute ischemic stroke. The BOBBY Balloon Guide Catheter is currently approved in North America and Europe. It was designed to improve compatibility and navigability with the SOFIA Plus 6Fr Aspiration Catheter while simplifying balloon preparation. These advancements in neurovascular devices market are anticipated to boost market growth over the forecast period.

Key Neurovascular Devices Companies:

The following are the leading companies in the neurovascular devices market. These companies collectively hold the largest market share and dictate industry trends.

• Medtronic
• Stryker Corporation
• Terumo Corporation
• Penumbra, Inc.
• Johnson & Johnson Services, Inc.
• Integra LifeSciences Corporation
• Acandis GmbH
• Spiegelberg GmbH & Co. KG
• MicroPort Scientific Corporation
• ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

Order a free sample PDF of the Market Intelligence Study, published by Grand View Research.